Theresa Matkovits
Overview
Theresa Matkovits received an average of $889K in total compensation, including $316K in salary, at Matinas BioPharma Holdings from 2018 to 2022.
Source: SEC filings on September 19, 2023, September 22, 2022, and October 1, 2020.
Related executives
We found nine more executives who work or worked at Matinas BioPharma Holdings.
Jerome Jabbour
Matinas BioPharma Holdings
Chief Executive Officer
James Ferguson
Matinas BioPharma Holdings
Chief Medical Officer
Keith Kucinski
Matinas BioPharma Holdings
Chief Financial Officer
Roelof Rongen
Matinas BioPharma Holdings
Chief Executive Officer
Raphael Mannino
Matinas BioPharma Holdings
Chief Scientific Officer
Gary Gaglione
Matinas BioPharma Holdings
Chief Financial Officer
Dominick DiPaolo
Matinas BioPharma Holdings
Former Senior Vice President, Quality and Regulatory Compliance
Douglas Kling
Matinas BioPharma Holdings
Senior Vice President, Clinical Development & Project Management
News
Matinas BioPharma Holdings CEO Jerome Jabbour's 2022 pay falls 55% to $1.7M
September 19, 2023
Matinas BioPharma Holdings CEO Jerome Jabbour's 2021 pay jumps 26% to $3.7M
September 22, 2022
Matinas BioPharma Holdings CEO Jerome Jabbour's 2019 pay rises 6% to $1.3M
October 1, 2020
Matinas BioPharma Holdings CEO Jerome Jabbour's 2018 pay slips 1% to $1.3M
September 24, 2019